Compare INDRAPRASTHA MEDICAL with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs THYROCARE TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL THYROCARE TECHNOLOGIES INDRAPRASTHA MEDICAL/
THYROCARE TECHNOLOGIES
 
P/E (TTM) x 16.0 36.0 44.5% View Chart
P/BV x 2.5 14.3 17.6% View Chart
Dividend Yield % 0.0 2.2 -  

Financials

 INDRAPRASTHA MEDICAL   THYROCARE TECHNOLOGIES
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-21
THYROCARE TECHNOLOGIES
Mar-21
INDRAPRASTHA MEDICAL/
THYROCARE TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs701,212 5.8%   
Low Rs31485 6.5%   
Sales per share (Unadj.) Rs66.993.6 71.5%  
Earnings per share (Unadj.) Rs0.321.4 1.2%  
Cash flow per share (Unadj.) Rs3.927.1 14.3%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Avg Dividend yield %02.9 0.0%  
Book value per share (Unadj.) Rs29.880.3 37.1%  
Shares outstanding (eoy) m91.6752.87 173.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.89.1 8.3%   
Avg P/E ratio x199.239.6 502.6%  
P/CF ratio (eoy) x13.031.3 41.6%  
Price / Book Value ratio x1.710.6 16.1%  
Dividend payout %0116.7 0.0%   
Avg Mkt Cap Rs m4,63944,869 10.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1,977581 340.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,1344,946 124.0%  
Other income Rs m7124 5.5%   
Total revenues Rs m6,1415,071 121.1%   
Gross profit Rs m4031,713 23.5%  
Depreciation Rs m333303 110.0%   
Interest Rs m339 383.4%   
Profit before tax Rs m431,525 2.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20393 5.0%   
Profit after tax Rs m231,132 2.1%  
Gross profit margin %6.634.6 19.0%  
Effective tax rate %45.725.8 177.3%   
Net profit margin %0.422.9 1.7%  
BALANCE SHEET DATA
Current assets Rs m1,4142,381 59.4%   
Current liabilities Rs m1,159951 121.9%   
Net working cap to sales %4.228.9 14.4%  
Current ratio x1.22.5 48.7%  
Inventory Days Days2107 2.1%  
Debtors Days Days4033 121.6%  
Net fixed assets Rs m2,9053,020 96.2%   
Share capital Rs m917529 173.4%   
"Free" reserves Rs m1,8113,715 48.7%   
Net worth Rs m2,7284,243 64.3%   
Long term debt Rs m00-   
Total assets Rs m4,3205,402 80.0%  
Interest coverage x2.3176.3 1.3%   
Debt to equity ratio x00-  
Sales to assets ratio x1.40.9 155.1%   
Return on assets %1.321.1 6.2%  
Return on equity %0.926.7 3.2%  
Return on capital %2.836.2 7.7%  
Exports to sales %00-   
Imports to sales %00.7 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA33 0.0%   
Fx inflow Rs m62052 1,199.0%   
Fx outflow Rs m5233 156.2%   
Net fx Rs m56818 3,102.2%   
CASH FLOW
From Operations Rs m2791,160 24.0%  
From Investments Rs m-202-502 40.1%  
From Financial Activity Rs m-31-616 5.1%  
Net Cashflow Rs m4642 108.2%  

Share Holding

Indian Promoters % 49.4 71.2 69.3%  
Foreign collaborators % 1.6 0.0 -  
Indian inst/Mut Fund % 0.1 18.7 0.3%  
FIIs % 0.0 12.1 0.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 28.8 170.3%  
Shareholders   58,001 62,936 92.2%  
Pledged promoter(s) holding % 0.0 100.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   TEJNAKSH HEALTHCARE  N.G.IND.LTD.  LOTUS EYE CARE  ASPIRA PATHLAB & DIAGNOSTICS   KMC SPECIALITY HOSPITALS  



Today's Market

Sensex, Nifty Continue Downtrend to End Lower for 4th Day; Metal & IT Stocks Drag(Closing)

After opening the day on a positive note, Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

THYROCARE TECHNOLOGIES 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of THYROCARE TECHNOLOGIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of THYROCARE TECHNOLOGIES. Also includes updates on the valuation of THYROCARE TECHNOLOGIES.

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Oct 22, 2021 (Close)

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL 5-YR ANALYSIS

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS